http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001513551-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 1998-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2001513551-A
titleOfInvention Treatment of urinary incontinence
abstract (57) [Summary]nThe present invention relates to a homovanilloid compound in an effective dose to the bladder mucosa of a patient suffering from neurogenic urinary dysfunction, in particular an RTX, TYX, 20-homovanillyl-mezelein or 20-homovanillyl-12-deoxyphorbol-13-phenylacetate group. A method for treating neurological urinary dysfunction, comprising contacting a compound selected from the group consisting of: The present invention includes a method of treating impulse incontinence with detrusor hyperreflexia (DH). The invention also includes the treatment of hyperesthesia due to prostatic hypertrophy or interstitial tissue inflammation and other neurological conditions that result in increased frequency of urination or reduced bladder capacity, with or without overt incontinence.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011505370-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004007495-A1
priorityDate 1997-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527754
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4802586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VGE8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586895
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1476581
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502831
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HKW2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ868G6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426090870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4409936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702546
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1476581
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ295T3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548943
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2AIS8

Total number of triples: 41.